These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 27628059)
21. TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients. Fernandez SV; Bingham C; Fittipaldi P; Austin L; Palazzo J; Palmer G; Alpaugh K; Cristofanilli M Breast Cancer Res; 2014 Oct; 16(5):445. PubMed ID: 25307991 [TBL] [Abstract][Full Text] [Related]
22. Personalized Treatment Through Detection and Monitoring of Genetic Aberrations in Single Circulating Tumor Cells. Tan SJ; Yeo T; Sukhatme SA; Kong SL; Lim WT; Lim CT Adv Exp Med Biol; 2017; 994():255-273. PubMed ID: 28560679 [TBL] [Abstract][Full Text] [Related]
23. Detection of EpCAM positive and negative circulating tumor cells in metastatic breast cancer patients. Königsberg R; Obermayr E; Bises G; Pfeiler G; Gneist M; Wrba F; de Santis M; Zeillinger R; Hudec M; Dittrich C Acta Oncol; 2011 Jun; 50(5):700-10. PubMed ID: 21261508 [TBL] [Abstract][Full Text] [Related]
24. High-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining. Campton DE; Ramirez AB; Nordberg JJ; Drovetto N; Clein AC; Varshavskaya P; Friemel BH; Quarre S; Breman A; Dorschner M; Blau S; Blau CA; Sabath DE; Stilwell JL; Kaldjian EP BMC Cancer; 2015 May; 15():360. PubMed ID: 25944336 [TBL] [Abstract][Full Text] [Related]
25. Quantitative Whole Genome Sequencing of Circulating Tumor Cells Enables Personalized Combination Therapy of Metastatic Cancer. Gulbahce N; Magbanua MJM; Chin R; Agarwal MR; Luo X; Liu J; Hayden DM; Mao Q; Ciotlos S; Li Z; Chen Y; Chen X; Li Y; Zhang RY; Lee K; Tearle R; Park E; Drmanac S; Rugo HS; Park JW; Drmanac R; Peters BA Cancer Res; 2017 Aug; 77(16):4530-4541. PubMed ID: 28811315 [TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort. Jansson S; Bendahl PO; Larsson AM; Aaltonen KE; Rydén L BMC Cancer; 2016 Jul; 16():433. PubMed ID: 27390845 [TBL] [Abstract][Full Text] [Related]
27. EpCAM based capture detects and recovers circulating tumor cells from all subtypes of breast cancer except claudin-low. Ring A; Mineyev N; Zhu W; Park E; Lomas C; Punj V; Yu M; Barrak D; Forte V; Porras T; Tripathy D; Lang JE Oncotarget; 2015 Dec; 6(42):44623-34. PubMed ID: 26556851 [TBL] [Abstract][Full Text] [Related]
28. Single-Cell Phenotypic and Molecular Characterization of Circulating Tumor Cells Isolated from Cryopreserved Peripheral Blood Mononuclear Cells of Patients with Lung Cancer and Sarcoma. Vismara M; Reduzzi C; Silvestri M; Murianni F; Lo Russo G; Fortunato O; Motta R; Lanzoni D; Giovinazzo F; Miodini P; Pasquali S; Suatoni P; Pastorino U; Roz L; Sozzi G; Cappelletti V; Bertolini G Clin Chem; 2022 May; 68(5):691-701. PubMed ID: 35304611 [TBL] [Abstract][Full Text] [Related]
29. Clinical validation of an ultra high-throughput spiral microfluidics for the detection and enrichment of viable circulating tumor cells. Khoo BL; Warkiani ME; Tan DS; Bhagat AA; Irwin D; Lau DP; Lim AS; Lim KH; Krisna SS; Lim WT; Yap YS; Lee SC; Soo RA; Han J; Lim CT PLoS One; 2014; 9(7):e99409. PubMed ID: 24999991 [TBL] [Abstract][Full Text] [Related]
30. Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms. Paoletti C; Cani AK; Larios JM; Hovelson DH; Aung K; Darga EP; Cannell EM; Baratta PJ; Liu CJ; Chu D; Yazdani M; Blevins AR; Sero V; Tokudome N; Thomas DG; Gersch C; Schott AF; Wu YM; Lonigro R; Robinson DR; Chinnaiyan AM; Bischoff FZ; Johnson MD; Park BH; Hayes DF; Rae JM; Tomlins SA Cancer Res; 2018 Feb; 78(4):1110-1122. PubMed ID: 29233927 [TBL] [Abstract][Full Text] [Related]
31. High-purity and label-free isolation of circulating tumor cells (CTCs) in a microfluidic platform by using optically-induced-dielectrophoretic (ODEP) force. Huang SB; Wu MH; Lin YH; Hsieh CH; Yang CL; Lin HC; Tseng CP; Lee GB Lab Chip; 2013 Apr; 13(7):1371-83. PubMed ID: 23389102 [TBL] [Abstract][Full Text] [Related]
32. Circulating tumor cells in patients with breast cancer: monitoring chemotherapy success. Ušiaková Z; Mikulová V; Pintérová D; Brychta M; Valchář J; Kubecová M; Tesařová P; Bobek V; Kološtová K In Vivo; 2014; 28(4):605-14. PubMed ID: 24982230 [TBL] [Abstract][Full Text] [Related]
33. Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer. Court CM; Ankeny JS; Sho S; Hou S; Li Q; Hsieh C; Song M; Liao X; Rochefort MM; Wainberg ZA; Graeber TG; Tseng HR; Tomlinson JS J Mol Diagn; 2016 Sep; 18(5):688-696. PubMed ID: 27375074 [TBL] [Abstract][Full Text] [Related]
34. All-in-one centrifugal microfluidic device for size-selective circulating tumor cell isolation with high purity. Lee A; Park J; Lim M; Sunkara V; Kim SY; Kim GH; Kim MH; Cho YK Anal Chem; 2014 Nov; 86(22):11349-56. PubMed ID: 25317565 [TBL] [Abstract][Full Text] [Related]
35. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer. Jiang R; Lu YT; Ho H; Li B; Chen JF; Lin M; Li F; Wu K; Wu H; Lichterman J; Wan H; Lu CL; OuYang W; Ni M; Wang L; Li G; Lee T; Zhang X; Yang J; Rettig M; Chung LW; Yang H; Li KC; Hou Y; Tseng HR; Hou S; Xu X; Wang J; Posadas EM Oncotarget; 2015 Dec; 6(42):44781-93. PubMed ID: 26575023 [TBL] [Abstract][Full Text] [Related]
36. Highly sensitive detection and mutational analysis of lung cancer circulating tumor cells using integrated combined immunomagnetic beads with a droplet digital PCR chip. Gao W; Huang T; Yuan H; Yang J; Jin Q; Jia C; Mao G; Zhao J Talanta; 2018 Aug; 185():229-236. PubMed ID: 29759193 [TBL] [Abstract][Full Text] [Related]
37. Mutational analysis of circulating tumor cells from colorectal cancer patients and correlation with primary tumor tissue. Lyberopoulou A; Aravantinos G; Efstathopoulos EP; Nikiteas N; Bouziotis P; Isaakidou A; Papalois A; Marinos E; Gazouli M PLoS One; 2015; 10(4):e0123902. PubMed ID: 25902072 [TBL] [Abstract][Full Text] [Related]
38. Slanted spiral microfluidics for the ultra-fast, label-free isolation of circulating tumor cells. Warkiani ME; Guan G; Luan KB; Lee WC; Bhagat AA; Chaudhuri PK; Tan DS; Lim WT; Lee SC; Chen PC; Lim CT; Han J Lab Chip; 2014 Jan; 14(1):128-37. PubMed ID: 23949794 [TBL] [Abstract][Full Text] [Related]
39. Negative Enrichment and Isolation of Circulating Tumor Cells for Whole Genome Amplification. Kanwar N; Done SJ Methods Mol Biol; 2017; 1634():143-152. PubMed ID: 28819847 [TBL] [Abstract][Full Text] [Related]
40. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound. Catenacci DV; Chapman CG; Xu P; Koons A; Konda VJ; Siddiqui UD; Waxman I Gastroenterology; 2015 Dec; 149(7):1794-1803.e4. PubMed ID: 26341722 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]